Spots Global Cancer Trial Database for stereotactic body radiotherapy (sbrt)
Every month we try and update this database with for stereotactic body radiotherapy (sbrt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation | NCT06218420 | Hepatocellular ... | Stereotactic Bo... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | NCT04435938 | Head and Neck N... Squamous Cell C... Squamous Skin C... | Stereotactic Bo... | 60 Years - | McMaster University | |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors | NCT04572451 | Melanoma Carcinoma, Rena... Unresectable So... | nivolumab BMS-986253 Stereotactic Bo... | 18 Years - | University of Pittsburgh | |
| A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer | NCT05079698 | Prostate Cancer | 177Lu-PSMA-617 Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) | NCT04255836 | Carcinoma, Non-... | Durvalumab the first line ... stereotactic bo... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors | NCT05915481 | Advanced Solid ... Stereotactic Bo... Immune Checkpoi... Safety Efficacy | Cadonilimab Stereotactic bo... | 18 Years - 75 Years | Peking University Third Hospital | |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
| ABlative Radiotherapy (for) Unfavorable Prostate Tumors | NCT04831983 | Prostate Cancer | 18 Years - 90 Years | University of Milano Bicocca | ||
| Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer | NCT04262154 | Metastatic Pros... | Atezolizumab Abiraterone Prednisone GnRH analog Stereotactic Bo... Enzalutamide Follow up | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma | NCT02406183 | Melanoma Effects of Immu... Adverse Effect ... | Stereotactic bo... Ipilimumab | 18 Years - | University Hospital, Ghent | |
| Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867) | NCT03924869 | Non-Small Cell ... | Stereotactic Bo... Pembrolizumab Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors | NCT02608385 | Solid Tumor | Stereotactic bo... Pembrolizumab | 18 Years - | University of Chicago | |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors | NCT02581384 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar... | Stereotactic Bo... | - 21 Years | Dana-Farber Cancer Institute | |
| Study of Pembrolizumab and Radiotherapy in Liver Cancer | NCT03316872 | Hepatocellular ... | Pembrolizumab Stereotactic Bo... | 18 Years - | University Health Network, Toronto | |
| Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma | NCT04166734 | Advanced Malign... | Pembrolizumab Stereotactic Bo... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| Span-C-SBRT for Pancreatic Cancer | NCT03505229 | High Risk Local... | Stereotactic Bo... | 18 Years - 86 Years | Royal North Shore Hospital | |
| Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma | NCT03099265 | Pancreatic Canc... | neoadjuvant mFO... Stereotactic bo... | 18 Years - | Yale University | |
| Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer | NCT06195254 | Stereotactic Bo... PD-1 Inhibitors Pancreatic Canc... | Stereotactic bo... PD-1 blocking a... | 18 Years - 80 Years | Peking University Third Hospital | |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors | NCT02581384 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar... | Stereotactic Bo... | - 21 Years | Dana-Farber Cancer Institute | |
| MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer | NCT05974475 | Lung Neoplasm M... | SBRT Surgery | 18 Years - | European Institute of Oncology | |
| Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer | NCT00350142 | Pancreatic Canc... | Stereotactic Bo... Gemcitabine 4D pancreatic p... FDG PET scan | 18 Years - 90 Years | Stanford University | |
| Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT02684253 | Head and Neck S... | Nivolumab Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy | NCT04848909 | Prostate Cancer | stereotactic bo... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma | NCT06048484 | Pancreatic Duct... | Stereotactic bo... Zimberelimab Quemliclustat Etrumadenant Modified FOLFIR... | 18 Years - | Columbia University | |
| MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer | NCT05974475 | Lung Neoplasm M... | SBRT Surgery | 18 Years - | European Institute of Oncology | |
| FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer | NCT02839265 | Non-small Cell ... | FLT3 Ligand The... Stereotactic Bo... | 18 Years - | Albert Einstein College of Medicine | |
| Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors | NCT05469490 | Advanced Solid ... | Stereotactic Bo... navoximod NLG802 (indoxim... | 15 Years - | University of Pittsburgh | |
| Intraoperative Radiotherapy in Treating Spinal Metastases | NCT06093854 | Spinal Metastas... | Intraoperative ... Stereotactic bo... | 35 Years - 75 Years | Shanghai Changzheng Hospital | |
| Prostate Boost Irradiation With Stereotactic Body RT (SBRT) | NCT03380806 | Prostate Cancer | LHRH agonist Pelvic Radiatio... Stereotactic Bo... Conventional Ra... | 18 Years - 85 Years | Juravinski Cancer Center | |
| Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) | NCT02906397 | ADVANCED HEPATO... | Galunisertib 15... Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors | NCT05915481 | Advanced Solid ... Stereotactic Bo... Immune Checkpoi... Safety Efficacy | Cadonilimab Stereotactic bo... | 18 Years - 75 Years | Peking University Third Hospital | |
| Span-C-SBRT for Pancreatic Cancer | NCT03505229 | High Risk Local... | Stereotactic Bo... | 18 Years - 86 Years | Royal North Shore Hospital | |
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | NCT04435938 | Head and Neck N... Squamous Cell C... Squamous Skin C... | Stereotactic Bo... | 60 Years - | McMaster University | |
| WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases | NCT06243003 | SCLC,Extensive ... Brain Metastase... | HA-WBRT plus SB... | 18 Years - | Fudan University | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) | NCT04255836 | Carcinoma, Non-... | Durvalumab the first line ... stereotactic bo... | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | NCT03991962 | Pancreatic Canc... | mFOLFIRINOX Stereotactic bo... | 18 Years - | Yale University | |
| RFA vs. SBRT for Small HCC | NCT03898921 | Hepatocellular ... | stereotactic bo... Radiofrequency ... | 18 Years - 75 Years | Sun Yat-sen University | |
| Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer | NCT00350142 | Pancreatic Canc... | Stereotactic Bo... Gemcitabine 4D pancreatic p... FDG PET scan | 18 Years - 90 Years | Stanford University | |
| Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma | NCT01005875 | Hepatocellular ... Liver Cancer | Sorafenib Stereotactic Bo... | 19 Years - | University of Alabama at Birmingham | |
| Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer | NCT03599362 | Pancreatic Canc... | Nivolumab + Cab... Stereotactic Bo... | 18 Years - 100 Years | NYU Langone Health | |
| VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC) | NCT06394297 | Cervical Cancer | SBRT | 18 Years - | Fundacao Champalimaud | |
| To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors | NCT02410174 | Primary Tumor Renal Cell Carc... | Stereotactic Bo... | 18 Years - | Beth Israel Medical Center | |
| Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer | NCT03122496 | Metastatic Anap... | durvalumab tremelimumab Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer | NCT02065960 | Breast Neoplasm | Stereotactic bo... | 70 Years - | Juravinski Cancer Center | |
| Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer | NCT05802654 | Early Lung Canc... Stereotactic Bo... | SBRT | 18 Years - 80 Years | Peking University Third Hospital | |
| Prostate Boost Irradiation With Stereotactic Body RT (SBRT) | NCT03380806 | Prostate Cancer | LHRH agonist Pelvic Radiatio... Stereotactic Bo... Conventional Ra... | 18 Years - 85 Years | Juravinski Cancer Center | |
| Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors | NCT05915481 | Advanced Solid ... Stereotactic Bo... Immune Checkpoi... Safety Efficacy | Cadonilimab Stereotactic bo... | 18 Years - 75 Years | Peking University Third Hospital | |
| Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients | NCT01968941 | Non-small Cell ... | Stereotactic Bo... Conventional Ra... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma | NCT03609268 | Recurrent Hepat... Microwave Ablat... Stereotactic Bo... | microwave ablat... stereotactic bo... | 18 Years - 80 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer. | NCT06052683 | Prostate Cancer | Low-Dose Rate B... Stereotactic Bo... | 18 Years - | CHU de Quebec-Universite Laval | |
| Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT) | NCT01290562 | Spinal Metastas... | Stereotactic Bo... | 19 Years - | University Health Network, Toronto | |
| Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer | NCT03122496 | Metastatic Anap... | durvalumab tremelimumab Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location | NCT04925583 | Lung Cancer | Stereotactic bo... | 18 Years - | University Hospital Heidelberg | |
| Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer | NCT04262154 | Metastatic Pros... | Atezolizumab Abiraterone Prednisone GnRH analog Stereotactic Bo... Enzalutamide Follow up | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection | NCT01535209 | Brain Metastase... | stereotactic bo... Whole-Brain Rad... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Stereotactic PAncreatic RadioTherapy Adjuvant Therapy | NCT05043857 | Pancreas Cancer | Stereotactic Bo... | 18 Years - | Istituto Clinico Humanitas | |
| Study of Pembrolizumab and Radiotherapy in Liver Cancer | NCT03316872 | Hepatocellular ... | Pembrolizumab Stereotactic Bo... | 18 Years - | University Health Network, Toronto | |
| Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer | NCT01622621 | Lung Neoplasms | Sublobar Resect... Stereotactic Bo... | 18 Years - | Mayo Clinic | |
| Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT) | NCT01290562 | Spinal Metastas... | Stereotactic Bo... | 19 Years - | University Health Network, Toronto | |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | NCT01446458 | Cancer of Pancr... Cancer of the P... Neoplasms, Panc... Pancreas Cancer Pancreas Neopla... | Modified FOLFIR... Stereotactic Bo... | 21 Years - | Emory University | |
| Daily vs. Non-Daily SBRT for NSCLC | NCT03624907 | Non-small Cell ... | Daily Stereotac... Non-Daily Stere... | 18 Years - | University of Florida | |
| Stereotactic PAncreatic RadioTherapy Adjuvant Therapy | NCT05043857 | Pancreas Cancer | Stereotactic Bo... | 18 Years - | Istituto Clinico Humanitas | |
| Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients | NCT01968941 | Non-small Cell ... | Stereotactic Bo... Conventional Ra... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife | NCT02716207 | Pancreatic Tumo... | CyberKnife | 18 Years - 75 Years | Changhai Hospital | |
| Intraoperative Radiotherapy in Treating Spinal Metastases | NCT06093854 | Spinal Metastas... | Intraoperative ... Stereotactic bo... | 35 Years - 75 Years | Shanghai Changzheng Hospital | |
| WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases | NCT06243003 | SCLC,Extensive ... Brain Metastase... | HA-WBRT plus SB... | 18 Years - | Fudan University | |
| RFA Versus SBRT for Recurrent Small HCC | NCT04047173 | Hepatocellular ... | stereotactic bo... Radiofrequency ... | 18 Years - 75 Years | Sun Yat-sen University | |
| A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer | NCT02643498 | Pancreatic Canc... | Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer | NCT02837263 | Colorectal Canc... Colorectal Aden... Stage IVA Color... Stage IVB Color... Metastatic Carc... | Stereotactic bo... Pembrolizumab | 18 Years - | University of Wisconsin, Madison | |
| Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer | NCT01926197 | Pancreatic Canc... | Oxaliplatin Irinotecan Leucovorin 5FU Stereotactic Bo... | 18 Years - | Stanford University | |
| POSE - POs Surgery Endometrial Cancer | NCT06394258 | Endometrial Can... | Stereotactic bo... | 18 Years - | Fundacao Champalimaud | |
| Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | NCT03991962 | Pancreatic Canc... | mFOLFIRINOX Stereotactic bo... | 18 Years - | Yale University | |
| Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors | NCT05469490 | Advanced Solid ... | Stereotactic Bo... navoximod NLG802 (indoxim... | 15 Years - | University of Pittsburgh | |
| POSE - POs Surgery Endometrial Cancer | NCT06394258 | Endometrial Can... | Stereotactic bo... | 18 Years - | Fundacao Champalimaud | |
| Span-C-SBRT for Pancreatic Cancer | NCT03505229 | High Risk Local... | Stereotactic Bo... | 18 Years - 86 Years | Royal North Shore Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
